PRAX – praxis precision medicines, inc. (US:NASDAQ)
Stock Stats
News
Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus [Yahoo! Finance]
Is It Too Late To Reassess Praxis Precision Medicines (PRAX) After Its 1-Year Surge? [Yahoo! Finance]
Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
Praxis Precision Medicines (NASDAQ:PRAX) had its price target raised by analysts at Wedbush from $83.00 to $95.00. They now have an "underperform" rating on the stock.
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress [Yahoo! Finance]
Form 4 Praxis Precision Medicin For: Jan 12 Filed by: Mastrocola Lauren
Form 4 Praxis Precision Medicin For: Jan 12 Filed by: Sniecinski Megan
Form 4 Praxis Precision Medicin For: Jan 12 Filed by: Nemiroff Alex
Form 4 Praxis Precision Medicin For: Jan 12 Filed by: Kelly Timothy Edwin
Form 4 Praxis Precision Medicin For: Jan 08 Filed by: Mastrocola Lauren
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.